DZ2510A1 - Composition comprising 5-Ä4-Ä2- (n-methyl-n- (2-pyridyl) amino) ethoxyÜbenzylÜthiazolidine-2,4-dione and process for its preparation. - Google Patents

Composition comprising 5-Ä4-Ä2- (n-methyl-n- (2-pyridyl) amino) ethoxyÜbenzylÜthiazolidine-2,4-dione and process for its preparation.

Info

Publication number
DZ2510A1
DZ2510A1 DZ980120A DZ980120A DZ2510A1 DZ 2510 A1 DZ2510 A1 DZ 2510A1 DZ 980120 A DZ980120 A DZ 980120A DZ 980120 A DZ980120 A DZ 980120A DZ 2510 A1 DZ2510 A1 DZ 2510A1
Authority
DZ
Algeria
Prior art keywords
ethoxyübenzylüthiazolidine
dione
pyridyl
amino
methyl
Prior art date
Application number
DZ980120A
Other languages
French (fr)
Inventor
Jai Patel
Hamish Ross
Jeffrey Roger Granett
Robin Price
Nigel Wray
Original Assignee
Smithkline Beecham Corp
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9712851.6A external-priority patent/GB9712851D0/en
Application filed by Smithkline Beecham Corp, Smithkline Beecham Plc filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of DZ2510A1 publication Critical patent/DZ2510A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
DZ980120A 1997-06-05 1998-06-03 Composition comprising 5-Ä4-Ä2- (n-methyl-n- (2-pyridyl) amino) ethoxyÜbenzylÜthiazolidine-2,4-dione and process for its preparation. DZ2510A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9711683.4A GB9711683D0 (en) 1997-06-05 1997-06-05 Composition
GBGB9712851.6A GB9712851D0 (en) 1997-06-18 1997-06-18 Composition

Publications (1)

Publication Number Publication Date
DZ2510A1 true DZ2510A1 (en) 2003-01-25

Family

ID=26311662

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980120A DZ2510A1 (en) 1997-06-05 1998-06-03 Composition comprising 5-Ä4-Ä2- (n-methyl-n- (2-pyridyl) amino) ethoxyÜbenzylÜthiazolidine-2,4-dione and process for its preparation.

Country Status (29)

Country Link
EP (1) EP0998284A1 (en)
JP (1) JP2001521553A (en)
KR (1) KR20010013410A (en)
CN (3) CN1112926C (en)
AP (1) AP1214A (en)
AR (2) AR008198A1 (en)
AU (1) AU8215098A (en)
BG (1) BG104048A (en)
BR (1) BR9810405A (en)
CA (2) CA2333352A1 (en)
CO (1) CO4940400A1 (en)
DZ (1) DZ2510A1 (en)
EA (1) EA002384B1 (en)
GB (1) GB9711683D0 (en)
HU (1) HUP0004070A3 (en)
ID (1) ID24264A (en)
IL (1) IL133074A0 (en)
MX (1) MXPA99011322A (en)
NO (2) NO995938L (en)
NZ (2) NZ523725A (en)
OA (1) OA11306A (en)
PE (1) PE78899A1 (en)
PL (1) PL337201A1 (en)
SK (1) SK164899A3 (en)
TR (2) TR200002790T2 (en)
TW (1) TW570797B (en)
UY (1) UY25032A1 (en)
WO (1) WO1998055122A1 (en)
ZA (2) ZA984826B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040248945A1 (en) 1999-04-23 2004-12-09 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
CO5170421A1 (en) 1999-04-23 2002-06-27 Smithkline Beecham Plc NEW MALEICO PHARMACEUTICAL COMPOUND
DZ3155A1 (en) 1999-04-23 2000-11-02 Smithkline Beecham Plc New pharmaceutical composition.
GB0021978D0 (en) 2000-09-07 2000-10-25 Smithkline Beecham Plc Novel pharmaceutical
GB0127805D0 (en) * 2001-11-20 2002-01-09 Smithkline Beecham Plc Pharmaceutical composition
GB0129871D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB0129876D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
AU2002350965A1 (en) * 2001-12-13 2003-06-23 Smithkline Beecham Plc Toluenesulfonate hydrates of a thiazolidinedione derivative
GB0130509D0 (en) * 2001-12-20 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
DE06252444T8 (en) * 2006-05-09 2009-03-19 Teva Pharmaceutical Industries Ltd. 2-N- {5 - [[4- [2- (Methyl-2-pyridinylamino) -ethoxy] -phenyl] -methyl] -2,4-thiazolidinedione-succinic acid, method of preparation and compositions with rosiglitazone maleate
US7435741B2 (en) 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
WO2015008234A1 (en) * 2013-07-17 2015-01-22 Glenmark Pharmaceuticals S.A. Bicyclic heterocyclic compounds as ror gamma modulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3856378T2 (en) * 1987-09-04 2000-05-11 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
EP0777469A1 (en) * 1994-02-10 1997-06-11 Smithkline Beecham Plc Use of insulin sensitisers for treating renal diseases
CN1192683A (en) * 1995-08-10 1998-09-09 沃尼尔·朗伯公司 Method for reducing amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus
AU7604596A (en) * 1995-11-17 1997-06-11 Warner-Lambert Company A method of treating myotonic dystrophy
NZ314406A (en) * 1996-03-18 2000-12-22 Sankyo Co Treatment or prophylaxis of pancreatitis with a medicament containing an insulin sensitiser including oxazoles and thiazoles
CN1230114A (en) * 1996-07-12 1999-09-29 史密丝克莱恩比彻姆有限公司 Novel treatment of leptine resistance

Also Published As

Publication number Publication date
OA11306A (en) 2003-10-22
IL133074A0 (en) 2001-03-19
BG104048A (en) 2000-07-31
GB9711683D0 (en) 1997-08-06
NZ513922A (en) 2001-09-28
CN1430959A (en) 2003-07-23
TW570797B (en) 2004-01-11
CN1112926C (en) 2003-07-02
BR9810405A (en) 2000-08-29
TR200002790T2 (en) 2001-11-21
KR20010013410A (en) 2001-02-26
NO995938L (en) 2000-02-02
CA2292629C (en) 2004-01-06
TR199902963T2 (en) 2000-02-21
HUP0004070A2 (en) 2002-02-28
ZA9811572B (en) 1999-07-22
AP1214A (en) 2003-10-08
NO995938D0 (en) 1999-12-03
AR008198A1 (en) 1999-12-29
JP2001521553A (en) 2001-11-06
HUP0004070A3 (en) 2002-03-28
CN1259050A (en) 2000-07-05
NO20040738L (en) 2000-02-02
UY25032A1 (en) 1998-11-26
CO4940400A1 (en) 2000-07-24
AP9901696A0 (en) 1999-12-31
AU8215098A (en) 1998-12-21
CA2292629A1 (en) 1998-12-10
NZ523725A (en) 2004-09-24
AR015120A1 (en) 2001-04-18
ZA984826B (en) 1999-08-03
EA199901116A1 (en) 2000-06-26
CN1526391A (en) 2004-09-08
PL337201A1 (en) 2000-08-14
CA2333352A1 (en) 1998-12-10
MXPA99011322A (en) 2004-12-02
ID24264A (en) 2000-07-13
EP0998284A1 (en) 2000-05-10
PE78899A1 (en) 1999-10-22
WO1998055122A1 (en) 1998-12-10
EA002384B1 (en) 2002-04-25
SK164899A3 (en) 2000-11-07

Similar Documents

Publication Publication Date Title
HUP0001539A3 (en) 2-(1-iminoethylamino)ethyl-homocysteine, process for its preparation and pharmaceutical compositions containing the same
DZ2457A1 (en) New nicotinamide derivatives, process for their preparation and pharmaceutical compositions containing them.
HUP0004024A3 (en) Azabenzimidazole-based compounds, process for their preparation and pharmaceutical composition thereof
EE05214B1 (en) Polyol-IFN-β conjugate, process for its preparation and pharmaceutical composition
DZ2172A1 (en) Triazole derivatives useful in therapy, process for their preparation and compositions containing them.
AU7640696A (en) Thiazolidinedione derivatives, method for preparing the derivatives and pharmaceutical compositions containing same
CY2369B1 (en) Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same.
ZA9811759B (en) Novel indole derivatives, processes for their preparation, their use and pharmaceutical compositions containing them.
DZ2197A1 (en) 6-Phenylpyridyl-2-amine derivatives, process for their preparation and pharmaceutical compositions containing them.
HUP0100243A3 (en) Insoluble compositions comprising insuline and/or insuline-analogs and their derivatives, process for preparation thereof and their use for controlling blood glucose
HUP9801357A3 (en) Imidazoline-, imidazole-, oxazoline and thiazoline derivatives, pharmaceutical compositions containing them and process for producing them
DZ2114A1 (en) Process for the preparation of (-) - cis-6 (s) -phenyl-5} 4- (2-pyrrolidine-1-ylethoxy) -phenylÜ-5,6,7,8-tetrahydronaphthalene-2- d-tartrate ol.
DZ3079A1 (en) Process for the preparation of 4-carboxy-amino-2-substituted-1,2,3,4 tetrahydroquinole.
CH689805A8 (en) Paroxetine methanesulfonate, process for its preparation and pharmaceutical compositions containing it.
ZA985406B (en) Pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical preparations containing these compounds.
IL136425A0 (en) Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use
DZ2188A1 (en) Quinoxalinedone derivatives, processes and intermediates for their preparation and pharmaceutical compositions containing them.
HUP0001744A3 (en) Thiazolidine-2,4-dione derivatives, process for obtaining them and pharmaceutical compositions containing same
DZ2510A1 (en) Composition comprising 5-Ä4-Ä2- (n-methyl-n- (2-pyridyl) amino) ethoxyÜbenzylÜthiazolidine-2,4-dione and process for its preparation.
DZ2641A1 (en) New processes for the preparation of omeprazole.
CU22890A3 (en) NEW PREPARATION PROCESS FOR PHENYLIMIDAZOLIDINE DERIVATIVES.
ZA9810033B (en) Process for the preparation of Thiazolidinedione Derivatives.
DK0838469T3 (en) 10,13,15-Trioxatricyclo (9.2.1 9.6) -pentadecanone derivatives, process for their preparation, and drugs containing these compounds
HUP0001551A3 (en) Improved method for producing thiazolidinediones, thiazolidinediones and pharmaceutical compositions containing the same
EE04260B1 (en) Pharmaceutical composition, process for its preparation and use